PETMED EXPRESS INC (PETS)
PetMed Express, Inc., through its various subsidiaries, operates as a prominent pet pharmacy across the United States. The company provides a comprehensive range of both prescribed and over-the-counter animal medications, health-related items, and other essential supplies for canines, felines, and equines. Their non-prescription offerings include products for flea and tick prevention, joint and bone care, vitamins, treats, nutritional supplements, hygiene essentials, and general pet supplies. For prescription needs, they supply heartworm and flea/tick preventatives, alongside medications for conditions such as arthritis, dermatitis, thyroid imbalances, diabetes, pain relief, and cardiovascular issues, often providing generic alternatives. Beyond pharmaceuticals, the company also retails pet food, bedding, crates, stairs, and various other accessories. PetMed Express engages with its clientele through multiple distribution channels: its official website, a dedicated mobile application, a telephone contact center, direct mail campaigns (like brochures and postcards), and television advertisements, frequently promoting its 1-800-PetMeds and PetMeds brands. The company was established in 1996 and is headquartered in Delray Beach, Florida.
Sector: Retail-Drug Stores and Proprietary Stores
Industry: Specialty Retail
PetMed Express, Inc.
1-25 of 1,236 filings
Recent SEC filings with analysis
- 8-KPetMed Express filed an 8-K disclosing that its Board approved an amendment and restatement of its 2024 Inducement Incentive Plan effective September 27, 2026,…
- 8-KPetMed Express (Nasdaq: PETS) appointed Tamar Elkeles, Ph.D.
- 8-KPetMed Express (Nasdaq: PETS) announced on September 17, 2026 the appointment of Jeff Willard as Chief Executive Officer and President and board director,…